Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,975 | -5,134 | -4,506 | -26,744 | -12,437 |
| Depreciation Amortization | 2,080 | 224 | 149 | 18,352 | 13 |
| Income taxes - deferred | N/A | N/A | N/A | 4 | N/A |
| Accounts receivable | -116 | -2,338 | -594 | -525 | -6 |
| Other Working Capital | -1,446 | -7,626 | -4,418 | 3,151 | -109 |
| Other Operating Activity | 127 | 2,350 | 594 | 514 | 10,709 |
| Operating Cash Flow | $-5,331 | $-12,525 | $-8,775 | $-5,248 | $-1,829 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -175 | -1,657 | -82 | -194 | N/A |
| Net Acquisitions | N/A | N/A | N/A | -14,348 | N/A |
| Purchase Sale Intangibles | -662 | -322 | -706 | -111 | N/A |
| Other Investing Activity | -662 | -322 | -574 | -78 | 0 |
| Investing Cash Flow | $-836 | $-1,979 | $-656 | $-14,619 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 3,319 |
| Debt Repayment | N/A | N/A | N/A | -1,900 | -475 |
| Common Stock Issued | 4,748 | 12,081 | 4,093 | 43,560 | N/A |
| Common Stock Repurchased | N/A | -3,140 | -541 | -99 | N/A |
| Other Financing Activity | 0 | 0 | -126 | -2,096 | 62 |
| Financing Cash Flow | $4,748 | $8,942 | $3,426 | $39,465 | $2,905 |
| Exchange Rate Effect | 856 | -1,043 | 472 | 184 | -20 |
| Beginning Cash Position | 9,687 | 16,292 | 21,826 | 2,045 | 990 |
| End Cash Position | 9,123 | 9,687 | 16,292 | 21,826 | 2,045 |
| Net Cash Flow | $-563 | $-6,606 | $-5,534 | $19,781 | $1,055 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,331 | -12,525 | -8,775 | -5,248 | -1,829 |
| Capital Expenditure | -175 | -1,657 | -82 | -194 | N/A |
| Free Cash Flow | -5,506 | -14,182 | -8,857 | -5,442 | -1,829 |